128 related articles for article (PubMed ID: 24047693)
1. SAD-A and AMPK kinases: the "yin and yang" regulators of mTORC1 signaling in pancreatic β cells.
Nie J; Han X; Shi Y
Cell Cycle; 2013 Nov; 12(21):3366-9. PubMed ID: 24047693
[TBL] [Abstract][Full Text] [Related]
2. SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling.
Nie J; Liu X; Lilley BN; Zhang H; Pan YA; Kimball SR; Zhang J; Zhang W; Wang L; Jefferson LS; Sanes JR; Han X; Shi Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13857-62. PubMed ID: 23922392
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 to AMPK switching underlies β-cell metabolic plasticity during maturation and diabetes.
Jaafar R; Tran S; Shah AN; Sun G; Valdearcos M; Marchetti P; Masini M; Swisa A; Giacometti S; Bernal-Mizrachi E; Matveyenko A; Hebrok M; Dor Y; Rutter GA; Koliwad SK; Bhushan A
J Clin Invest; 2019 Jul; 129(10):4124-4137. PubMed ID: 31265435
[TBL] [Abstract][Full Text] [Related]
4. AMPK--sensing energy while talking to other signaling pathways.
Hardie DG
Cell Metab; 2014 Dec; 20(6):939-52. PubMed ID: 25448702
[TBL] [Abstract][Full Text] [Related]
5. Serum- and glucocorticoid-induced kinase drives hepatic insulin resistance by directly inhibiting AMP-activated protein kinase.
Zhou B; Zhang Y; Li S; Wu L; Fejes-Toth G; Naray-Fejes-Toth A; Soukas AA
Cell Rep; 2021 Oct; 37(1):109785. PubMed ID: 34610303
[TBL] [Abstract][Full Text] [Related]
6. LKB1 and AMPK differentially regulate pancreatic β-cell identity.
Kone M; Pullen TJ; Sun G; Ibberson M; Martinez-Sanchez A; Sayers S; Nguyen-Tu MS; Kantor C; Swisa A; Dor Y; Gorman T; Ferrer J; Thorens B; Reimann F; Gribble F; McGinty JA; Chen L; French PM; Birzele F; Hildebrandt T; Uphues I; Rutter GA
FASEB J; 2014 Nov; 28(11):4972-85. PubMed ID: 25070369
[TBL] [Abstract][Full Text] [Related]
7. AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation.
Dai X; Jiang C; Jiang Q; Fang L; Yu H; Guo J; Yan P; Chi F; Zhang T; Inuzuka H; Asara JM; Wang P; Guo J; Wei W
Nat Metab; 2023 Feb; 5(2):265-276. PubMed ID: 36732624
[TBL] [Abstract][Full Text] [Related]
8. The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis.
Yuan T; Annamalai K; Naik S; Lupse B; Geravandi S; Pal A; Dobrowolski A; Ghawali J; Ruhlandt M; Gorrepati KDD; Azizi Z; Lim DS; Maedler K; Ardestani A
Nat Commun; 2021 Aug; 12(1):4928. PubMed ID: 34389720
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the actions of AMP-activated protein kinase in metabolic diseases: Systemic to molecular insights.
Weikel KA; Ruderman NB; Cacicedo JM
Metabolism; 2016 May; 65(5):634-645. PubMed ID: 27085772
[TBL] [Abstract][Full Text] [Related]
10. Integration of signals generated by nutrients, hormones, and exercise in skeletal muscle.
Kimball SR
Am J Clin Nutr; 2014 Jan; 99(1):237S-242S. PubMed ID: 24284445
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase.
Nguyen-Tu MS; Harris J; Martinez-Sanchez A; Chabosseau P; Hu M; Georgiadou E; Pollard A; Otero P; Lopez-Noriega L; Leclerc I; Sakamoto K; Schmoll D; Smith DM; Carling D; Rutter GA
Diabetologia; 2022 Jun; 65(6):997-1011. PubMed ID: 35294578
[TBL] [Abstract][Full Text] [Related]
12. The picky mTORC1 in metabolic enzyme degradation.
Chun Y; Fruman DA; Lee G
Mol Cell; 2024 Jun; 84(11):2011-2013. PubMed ID: 38848689
[TBL] [Abstract][Full Text] [Related]
13. The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.
Xie J; Herbert TP
Cell Mol Life Sci; 2012 Apr; 69(8):1289-304. PubMed ID: 22068611
[TBL] [Abstract][Full Text] [Related]
14. AMPK potentiation by LKB1 isoforms.
Thibert C; Perret C; Billaud M
Oncotarget; 2015 Nov; 6(34):35139-40. PubMed ID: 26486087
[No Abstract] [Full Text] [Related]
15. Arginine deficiency causes runting in the suckling period by selectively activating the stress kinase GCN2.
Marion V; Sankaranarayanan S; de Theije C; van Dijk P; Lindsey P; Lamers MC; Harding HP; Ron D; Lamers WH; Köhler SE
J Biol Chem; 2011 Mar; 286(11):8866-74. PubMed ID: 21239484
[TBL] [Abstract][Full Text] [Related]
16. Dihydroxyacetone phosphate signals glucose availability to mTORC1.
Orozco JM; Krawczyk PA; Scaria SM; Cangelosi AL; Chan SH; Kunchok T; Lewis CA; Sabatini DM
Nat Metab; 2020 Sep; 2(9):893-901. PubMed ID: 32719541
[TBL] [Abstract][Full Text] [Related]
17. AMPK: A metabolic checkpoint that regulates the growth of EGFR activated glioblastomas.
Guo D; Cloughesy TF; Radu CG; Mischel PS
Cell Cycle; 2010 Jan; 9(2):211-2. PubMed ID: 20023392
[No Abstract] [Full Text] [Related]
18. Signaling and Metabolism.
Chandel NS
Cold Spring Harb Perspect Biol; 2021 Feb; 13(2):. PubMed ID: 33526508
[No Abstract] [Full Text] [Related]
19. Embryonic cerebrospinal fluid nanovesicles carry evolutionarily conserved molecules and promote neural stem cell amplification.
Feliciano DM; Zhang S; Nasrallah CM; Lisgo SN; Bordey A
PLoS One; 2014; 9(2):e88810. PubMed ID: 24533152
[TBL] [Abstract][Full Text] [Related]
20. SAD kinases control the maturation of nerve terminals in the mammalian peripheral and central nervous systems.
Lilley BN; Krishnaswamy A; Wang Z; Kishi M; Frank E; Sanes JR
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1138-43. PubMed ID: 24395778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
